7,8-bicycloakyl-chroman derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S434000, C514S453000, C514S452000

Reexamination Certificate

active

07875607

ABSTRACT:
7,8-Bicyclic-chroman derivatives of Formula I:wherein the substituents are defined as in the specification or the pharmaceutically acceptable salts thereof, are disclosed. They are useful for the treatment of inflammatory disorders, neurodegenerative disorders and/or mitochondrial disorders. They are also useful in the manufacture of pharmaceutical formulations for the treatment of such conditions.

REFERENCES:
patent: 3154565 (1964-10-01), Linn et al.
patent: 3160638 (1964-12-01), Folkers et al.
patent: 3574627 (1971-04-01), Stern et al.
patent: 3801603 (1974-04-01), Hartmann et al.
patent: 4360532 (1982-11-01), Sundeen
patent: 4452801 (1984-06-01), Sundeen
patent: 4511685 (1985-04-01), Nissen et al.
patent: 4515975 (1985-05-01), Vogel et al.
patent: 4523024 (1985-06-01), Shiono et al.
patent: 4645845 (1987-02-01), Gehrken et al.
patent: 4694090 (1987-09-01), Shiono et al.
patent: 4716238 (1987-12-01), Timar et al.
patent: 4728650 (1988-03-01), Eziri
patent: 4780469 (1988-10-01), Toda et al.
patent: 4814346 (1989-03-01), Albert
patent: 4877810 (1989-10-01), Mickle et al.
patent: 4950684 (1990-08-01), Koszyk et al.
patent: 5015661 (1991-05-01), Walser
patent: 5055598 (1991-10-01), Ohuchida et al.
patent: 5082849 (1992-01-01), Huang et al.
patent: 5093353 (1992-03-01), Koszyk et al.
patent: 5099012 (1992-03-01), Wu et al.
patent: 5132310 (1992-07-01), Walser
patent: 5155130 (1992-10-01), Stanton et al.
patent: 5260294 (1993-11-01), Walser
patent: 5290797 (1994-03-01), Le Baut et al.
patent: 5326771 (1994-07-01), Heine et al.
patent: 5350751 (1994-09-01), Wagner et al.
patent: 5385931 (1995-01-01), Bigg et al.
patent: 5395834 (1995-03-01), Le Baut et al.
patent: 5424321 (1995-06-01), Hellberg et al.
patent: 5484810 (1996-01-01), Grisar et al.
patent: 5500444 (1996-03-01), Grisar et al.
patent: 5534536 (1996-07-01), Ohuchida et al.
patent: 5541199 (1996-07-01), Mewshaw
patent: 5607966 (1997-03-01), Hellberg et al.
patent: 5646149 (1997-07-01), Hellberg et al.
patent: 5663294 (1997-09-01), Colman et al.
patent: 5670667 (1997-09-01), Mewshaw
patent: 5672710 (1997-09-01), Beard et al.
patent: 5684039 (1997-11-01), Mewshaw
patent: 5719180 (1998-02-01), Shudo
patent: 5747528 (1998-05-01), Trivedi
patent: 5750544 (1998-05-01), Ohuchida et al.
patent: 5756521 (1998-05-01), Mewshaw
patent: 5811438 (1998-09-01), Hellberg et al.
patent: 5821130 (1998-10-01), Baldwin et al.
patent: 5821264 (1998-10-01), Lane et al.
patent: 5849755 (1998-12-01), Englert et al.
patent: 5874461 (1999-02-01), De Chaffoy de Courcelles et al.
patent: 5925673 (1999-07-01), Hellberg et al.
patent: 5981530 (1999-11-01), Ogata
patent: 5981572 (1999-11-01), Ellis et al.
patent: 5990142 (1999-11-01), Carganico
patent: 6034256 (2000-03-01), Carter et al.
patent: 6133277 (2000-10-01), Wigerinck et al.
patent: 6150402 (2000-11-01), Wechter et al.
patent: 6222051 (2001-04-01), Lee et al.
patent: 6235774 (2001-05-01), Fahrig et al.
patent: 6242479 (2001-06-01), Wechter
patent: 6331532 (2001-12-01), Murphy et al.
patent: 6331561 (2001-12-01), Fahrig et al.
patent: 6342602 (2002-01-01), Teng et al.
patent: 6387899 (2002-05-01), Berg et al.
patent: 6410589 (2002-06-01), Wechter
patent: 6417223 (2002-07-01), Sanders et al.
patent: 6479497 (2002-11-01), Berg et al.
patent: 6511966 (2003-01-01), Ghosh et al.
patent: 6518250 (2003-02-01), Yoshikawa et al.
patent: 6555575 (2003-04-01), Wechter
patent: 6596745 (2003-07-01), Gall
patent: 6645997 (2003-11-01), Sahoo et al.
patent: 6645998 (2003-11-01), Sanders
patent: 6881396 (2005-04-01), Cyr
patent: 6903227 (2005-06-01), Kanter et al.
patent: 6989138 (2006-01-01), Cyr et al.
patent: 7119117 (2006-10-01), Beinlich et al.
patent: 7514461 (2009-04-01), Wang et al.
patent: 2002/0016359 (2002-02-01), Hellberg et al.
patent: 2002/0052342 (2002-05-01), Murphy et al.
patent: 2002/0127252 (2002-09-01), Kramer et al.
patent: 2003/0069208 (2003-04-01), Murphy et al.
patent: 2003/0176448 (2003-09-01), Ghosh et al.
patent: 2004/0097433 (2004-05-01), Boddupalli et al.
patent: 2005/0065009 (2005-03-01), Lu et al.
patent: 3842029 (1990-06-01), None
patent: 0 535 283 (1993-04-01), None
patent: 60001177 (1985-01-01), None
patent: 61148173 (1986-07-01), None
patent: 08041008 (1996-02-01), None
patent: 10251247 (1998-09-01), None
patent: WO-87/05020 (1987-08-01), None
patent: WO-96/16957 (1996-06-01), None
patent: WO-01/05781 (2001-01-01), None
Christen, S. et al. (Apr. 1997). “γ-Tocopherol Traps Mutagenic Electrophiles Such as NOxand Complements α-Tocopherol: Physiological Implications,”Proc. Natl. Acad. Sci.94:3217-3222.
Dallacker, F. et al. (1991). “Derivatives of the Vitamin E Series. 2. Preparation of All-Rac-5-Prenyl-γ-Tocopherol,”Chemiker-Zeitung115(10:285-289.
Lang, D. (2002). “Cardiac Hypertrophy and Oxidative Stress: A Leap of Faith or Stark Reality?”Heart87:316-318.
Sknner, W.A. et al. (Jul. 1967). “Structure-Activity Relations in the Vitamin E Series. 1. Effects of 5-Methyl Substitution on 6-Hydroxy-2,2,5,7,8-Pentamethylchroman,”Journal of Medicinal Chemistry10(4):657-661.
Wolf, H. et al. (1981). “The Antioxidative Chromane Structure of α-Tocopherol Protects Against the Consequences of Arachidonic Acid Release in the Pulmonary Vascular Bed,”Klinische Wochenschrift59:463-465.
Wolf, H.R.D. et al. (1982). “Experimental and Clinical Results in Shock Lung Treatment with Vitamin E,”Annals New York Academy of Sciences393:392-410.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

7,8-bicycloakyl-chroman derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 7,8-bicycloakyl-chroman derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7,8-bicycloakyl-chroman derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2698338

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.